CureVac fails in pivotal COVID-19 vaccine trial

The Straits Times·2021-06-18 15:08

German biotech CureVac NV said on Wednesday its COVID-19 vaccine was only 47% effective in a late-stage trial, missing the study's main goal and throwing in ...

Health